{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:49:26Z","timestamp":1793411366177,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T00:00:00Z","timestamp":1302739200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1477-7819-9-40","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T18:18:06Z","timestamp":1305051486000},"source":"Crossref","is-referenced-by-count":12,"title":["Thick primary melanoma has a heterogeneous tumor biology: an institutional series"],"prefix":"10.1186","volume":"9","author":[{"given":"Ari-Nareg","family":"Meguerditchian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobby","family":"Asubonteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Lema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,14]]},"reference":[{"issue":"7","key":"792_CR1","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/jid.2008.423","volume":"129","author":"E Linos","year":"2009","unstructured":"Linos E: Increasing burden of melanoma in the United States. J Invest Dermatol. 2009, 129 (7): 1666-74. 10.1038\/jid.2008.423.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"792_CR2","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1001\/archsurg.1990.01410150044009","volume":"125","author":"D Coit","year":"1990","unstructured":"Coit D, Sauven P, Brennan M: Prognosis of thick cutaneous melanoma of the trunk and extremity. Arch Surg. 1990, 125 (3): 322-6.","journal-title":"Arch Surg"},{"issue":"16","key":"792_CR3","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001, 19 (16): 3635-48.","journal-title":"J Clin Oncol"},{"issue":"2","key":"792_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.1988.6.2.392","volume":"6","author":"CM Balch","year":"1988","unstructured":"Balch CM: Surgical controversies in melanoma. J Clin Oncol. 1988, 6 (2): 392-3.","journal-title":"J Clin Oncol"},{"issue":"1","key":"792_CR5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1200\/JCO.1988.6.1.163","volume":"6","author":"CM Balch","year":"1988","unstructured":"Balch CM: The role of elective lymph node dissection in melanoma: rationale, results, and controversies. J Clin Oncol. 1988, 6 (1): 163-72.","journal-title":"J Clin Oncol"},{"issue":"3","key":"792_CR6","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","volume":"224","author":"CM Balch","year":"1996","unstructured":"Balch CM: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996, 224 (3): 255-63. 10.1097\/00000658-199609000-00002. discussion 263-6","journal-title":"Ann Surg"},{"issue":"9105","key":"792_CR7","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","volume":"351","author":"N Cascinelli","year":"1998","unstructured":"Cascinelli N: Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998, 351 (9105): 793-6. 10.1016\/S0140-6736(97)08260-3.","journal-title":"Lancet"},{"issue":"6","key":"792_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1001\/archsurg.1987.01400180089017","volume":"122","author":"S Schneebaum","year":"1987","unstructured":"Schneebaum S: Cutaneous thick melanoma. Prognosis and treatment. Arch Surg. 1987, 122 (6): 707-11.","journal-title":"Arch Surg"},{"issue":"3","key":"792_CR9","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z","volume":"41","author":"FH Sim","year":"1978","unstructured":"Sim FH: A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer. 1978, 41 (3): 948-56. 10.1002\/1097-0142(197803)41:3<948::AID-CNCR2820410324>3.0.CO;2-Z.","journal-title":"Cancer"},{"issue":"5","key":"792_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1067\/mjd.2001.112346","volume":"44","author":"BS Cherpelis","year":"2001","unstructured":"Cherpelis BS: Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. J Am Acad Dermatol. 2001, 44 (5): 762-6. 10.1067\/mjd.2001.112346.","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"792_CR11","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10434-001-0749-2","volume":"8","author":"R Essner","year":"2001","unstructured":"Essner R, Morton DL: Does the tumor status of the regional lymph nodes really matter in melanoma?. Ann Surg Oncol. 2001, 8 (10): 749-51. 10.1007\/s10434-001-0749-2.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"792_CR12","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s10434-000-0160-4","volume":"7","author":"JE Gershenwald","year":"2000","unstructured":"Gershenwald JE: Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma. Ann Surg Oncol. 2000, 7 (2): 160-5. 10.1007\/s10434-000-0160-4.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"792_CR13","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1245\/ASO.2003.03.055","volume":"10","author":"GW Carlson","year":"2003","unstructured":"Carlson GW: Sentinel lymph node mapping for thick (>or = 4-mm) melanoma: should we be doing it?. Ann Surg Oncol. 2003, 10 (4): 408-15. 10.1245\/ASO.2003.03.055.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"792_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/BF02574479","volume":"9","author":"CR Ferrone","year":"2002","unstructured":"Ferrone CR: Multivariate prognostic model for patients with thick cutaneous melanoma: importance of sentinel lymph node status. Ann Surg Oncol. 2002, 9 (7): 637-45. 10.1007\/BF02574479.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"792_CR15","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1007\/s00268-009-0159-3","volume":"33","author":"L Vermeeren","year":"2009","unstructured":"Vermeeren L: Thick melanoma: prognostic value of positive sentinel nodes. World J Surg. 2009, 33 (11): 2464-8. 10.1007\/s00268-009-0159-3.","journal-title":"World J Surg"},{"issue":"6","key":"792_CR16","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1468-3083.2006.02072.x","volume":"21","author":"R Cecchi","year":"2007","unstructured":"Cecchi R: Sentinel lymph node biopsy in patients with thick (= 4 mm) melanoma: a single-centre experience. J Eur Acad Dermatol Venereol. 2007, 21 (6): 758-61. 10.1111\/j.1468-3083.2006.02072.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"792_CR17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1479-5876-6-62","volume":"6","author":"PA Ascierto","year":"2008","unstructured":"Ascierto PA, Kirkwood JM: Adjuvant therapy of melanoma with interferon: lessons of the past decade. J Transl Med. 2008, 6: 62-10.1186\/1479-5876-6-62.","journal-title":"J Transl Med"},{"issue":"1","key":"792_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1200\/JCO.2004.03.185","volume":"22","author":"BW Hancock","year":"2004","unstructured":"Hancock BW: Adjuvant interferon in high-risk melanoma: the AIM HIGH Study--United Kingdom Coordinating Committee on Cancer Research randomized study of adjuvant low-dose extended-duration interferon Alfa-2a in high-risk resected malignant melanoma. J Clin Oncol. 2004, 22 (1): 53-61. 10.1200\/JCO.2004.03.185.","journal-title":"J Clin Oncol"},{"issue":"12","key":"792_CR19","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","volume":"18","author":"JM Kirkwood","year":"2000","unstructured":"Kirkwood JM: High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690\/S9111\/C9190. J Clin Oncol. 2000, 18 (12): 2444-58.","journal-title":"J Clin Oncol"},{"issue":"9","key":"792_CR20","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","volume":"19","author":"JM Kirkwood","year":"2001","unstructured":"Kirkwood JM: High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH\/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694\/S9512\/C509801. J Clin Oncol. 2001, 19 (9): 2370-80.","journal-title":"J Clin Oncol"},{"issue":"1","key":"792_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","volume":"14","author":"JM Kirkwood","year":"1996","unstructured":"Kirkwood JM: Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996, 14 (1): 7-17.","journal-title":"J Clin Oncol"},{"issue":"36","key":"792_CR22","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","volume":"27","author":"CM Balch","year":"2009","unstructured":"Balch CM: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009, 27 (36): 6199-206. 10.1200\/JCO.2009.23.4799.","journal-title":"J Clin Oncol"},{"issue":"2","key":"792_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jso.20349","volume":"93","author":"CP Karakousis","year":"2006","unstructured":"Karakousis CP: Surgical procedures and lymphedema of the upper and lower extremity. J Surg Oncol. 2006, 93 (2): 87-91. 10.1002\/jso.20349.","journal-title":"J Surg Oncol"},{"key":"792_CR24","volume-title":"National Comprehensive Cancer Network Practice Guidelines in Oncology: Melanoma","author":"DG Coit","year":"2010","unstructured":"Coit DG: National Comprehensive Cancer Network Practice Guidelines in Oncology: Melanoma. 2010, [cited April 20th 2010], http:\/\/www.nccn.org\/professionals\/physician_gls\/PDF\/melanoma.pdf"},{"issue":"3","key":"792_CR25","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S1072-7515(98)00296-8","volume":"188","author":"SH Kim","year":"1999","unstructured":"Kim SH: Prognosis of thick cutaneous melanoma. J Am Coll Surg. 1999, 188 (3): 241-7. 10.1016\/S1072-7515(98)00296-8.","journal-title":"J Am Coll Surg"},{"issue":"16","key":"792_CR26","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001, 19 (16): 3622-34.","journal-title":"J Clin Oncol"},{"issue":"3","key":"792_CR27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.sla.0000181092.50141.fa","volume":"242","author":"DL Morton","year":"2005","unstructured":"Morton DL: Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005, 242 (3): 302-11. discussion 311-3","journal-title":"Ann Surg"},{"issue":"13","key":"792_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa060992","volume":"355","author":"DL Morton","year":"2006","unstructured":"Morton DL: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006, 355 (13): 1307-17. 10.1056\/NEJMoa060992.","journal-title":"N Engl J Med"},{"issue":"4","key":"792_CR29","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992, 127 (4): 392-9.","journal-title":"Arch Surg"},{"issue":"4","key":"792_CR30","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jso.20084","volume":"86","author":"KM McMasters","year":"2004","unstructured":"McMasters KM: Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004, 86 (4): 212-23. 10.1002\/jso.20084.","journal-title":"J Surg Oncol"},{"key":"792_CR31","doi-asserted-by":"crossref","unstructured":"Scoggins CR: Prognostic information from sentinel lymph node biopsy in patients with thick melanoma. Arch Surg. 145 (7): 622-7.","DOI":"10.1001\/archsurg.2010.115"},{"issue":"24","key":"792_CR32","doi-asserted-by":"publisher","first-page":"5752","DOI":"10.1002\/cncr.24660","volume":"115","author":"C Gajdos","year":"2009","unstructured":"Gajdos C: Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?. Cancer. 2009, 115 (24): 5752-60. 10.1002\/cncr.24660.","journal-title":"Cancer"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7819-9-40\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-9-40.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T01:45:16Z","timestamp":1637631916000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-9-40"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["792"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-9-40","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,14]]},"article-number":"40"}}